China Medicine Corp
OTC:CHME
Cash Flow Statement
Cash Flow Statement
China Medicine Corp
| Dec-2005 | Mar-2006 | Jun-2006 | Sep-2006 | Dec-2006 | Mar-2007 | Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
6
|
5
|
4
|
4
|
5
|
5
|
6
|
7
|
7
|
7
|
9
|
8
|
9
|
9
|
6
|
7
|
2
|
3
|
7
|
6
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
2
|
7
|
5
|
3
|
2
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(4)
|
(5)
|
(4)
|
(5)
|
(8)
|
(8)
|
(10)
|
(10)
|
(10)
|
(11)
|
(12)
|
(11)
|
(5)
|
(6)
|
0
|
(1)
|
7
|
10
|
2
|
1
|
|
| Cash from Operating Activities |
1
N/A
|
(0)
N/A
|
(1)
-520%
|
(1)
+5%
|
(2)
-276%
|
(2)
+23%
|
(3)
-100%
|
(3)
+2%
|
(2)
+31%
|
(3)
-12%
|
(2)
+14%
|
(1)
+45%
|
4
N/A
|
4
-7%
|
9
+124%
|
8
-3%
|
17
+100%
|
20
+17%
|
13
-33%
|
11
-18%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(5)
|
|
| Other Items |
1
|
0
|
(0)
|
(1)
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(7)
|
(9)
|
(10)
|
(10)
|
(8)
|
(6)
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(1)
-7 400%
|
(2)
-212%
|
(1)
+65%
|
(1)
+38%
|
0
N/A
|
1
+2 675%
|
(0)
N/A
|
(0)
+41%
|
(1)
-187%
|
(3)
-355%
|
(8)
-162%
|
(7)
+6%
|
(10)
-32%
|
(12)
-22%
|
(14)
-13%
|
(14)
-4%
|
(11)
+21%
|
(10)
+7%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
4
|
4
|
0
|
4
|
7
|
10
|
10
|
8
|
5
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
71
|
71
|
70
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
4
|
(0)
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
(4)
|
(2)
|
(9)
|
(13)
|
|
| Other |
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(65)
|
(57)
|
(52)
|
|
| Cash from Financing Activities |
(2)
N/A
|
2
N/A
|
2
N/A
|
3
+102%
|
3
+0%
|
3
-19%
|
6
+102%
|
6
N/A
|
8
+38%
|
5
-32%
|
2
-54%
|
2
N/A
|
0
-85%
|
0
N/A
|
0
N/A
|
3
+14 809%
|
(6)
N/A
|
4
N/A
|
5
+40%
|
5
-3%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(0)
N/A
|
2
N/A
|
0
-76%
|
1
+41%
|
0
-50%
|
1
+99%
|
2
+296%
|
3
+60%
|
5
+55%
|
3
-47%
|
0
-98%
|
(1)
N/A
|
(3)
-110%
|
(3)
-14%
|
(1)
+72%
|
(0)
+52%
|
(2)
-405%
|
9
N/A
|
7
-23%
|
6
-22%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
1
N/A
|
(1)
N/A
|
(1)
-86%
|
(2)
-65%
|
(3)
-35%
|
(2)
+27%
|
(4)
-81%
|
(3)
+24%
|
(3)
+11%
|
(3)
-4%
|
(3)
-2%
|
(4)
-47%
|
2
N/A
|
1
-22%
|
6
+405%
|
5
-16%
|
13
+162%
|
16
+21%
|
10
-37%
|
6
-36%
|
|